BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2017 8:34:13 AM | Browse: 1156 | Download: 1738
 |
Received |
|
2017-10-13 02:23 |
|
Peer-Review Started |
|
2017-10-13 07:11 |
|
First Decision by Editorial Office Director |
|
2017-11-08 01:18 |
|
Return for Revision |
|
2017-11-08 07:16 |
|
Revised |
|
2017-11-10 05:00 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-11-27 11:27 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-11-27 20:22 |
|
Articles in Press |
|
2017-11-27 20:22 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-12-05 09:02 |
|
Publish the Manuscript Online |
|
2017-12-12 08:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka and Mitsuhiko Moriyama |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| AMED |
|
| JSPS KAKENHI |
17K09404 |
|
| Corresponding Author |
Tatsuo Kanda, MD, PhD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi-ku, Tokyo 173-8610, Japan. kandat-cib@umin.ac.jp |
| Key Words |
Direct-acting antiviral agent; Genotype 1b; Hepatitis C virus; Resistance-associated substitutions |
| Core Tip |
In this minireview, we focused on the retreatment of patients with treatment failure of direct-acting antiviral agents against hepatitis C virus genotype 1b (HCV GT1b) infection. We summarized the retreatment regimens for patients with failure of peginterferon and ribavirin plus HCV NS3/4A inhibitors and for those with failure of HCV NS5A inhibitors. We also demonstrated the resistance-associated substitutions of HCV NS5B nucleos(t)ide inhibitors. Attention should be paid when selecting both the initial treatment and retreat regimens to completely eradicate HCV infection. |
| Publish Date |
2017-12-12 08:34 |
| Citation |
Kanda T, Nirei K, Matsumoto N, Higuchi T, Nakamura H, Yamagami H, Matsuoka S, Moriyama M. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World J Gastroenterol 2017; 23(46): 8120-8127 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i46/8120.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i46.8120 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
